Technical analysis of Gilead Sciences, Inc. (GILD): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions.
Price Performance
| 1 month | +15.72% |
| 3 months | +31.08% |
| Year-to-date | +39.06% |
| 1 year | +42.48% |
| 3 years | +112.84% |
| 5 years | +160.02% |
| 10 years | +135.39% |
52-Week Range
| 52-week High | $175.65 |
| 52-week Low | $114.02 |
| Avg Volume (90d) | 6.3M |
Technical Indicators
| SMA 50 | $150.87 |
| SMA 200 | $139.88 |
| Beta | 0.40 |
| 30-day Volatility (annualised) | 27.1% |
| Price vs SMA 50 | +13.1% |
| Price vs SMA 200 | +22.0% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $122.74 | |
| 2026-01 | $141.95 | +15.7% |
| 2026-02 | $148.95 | +4.9% |
| 2026-03 | $139.37 | -6.4% |
| 2026-04 | $130.84 | -6.1% |
| 2026-05 | $134.43 | +2.7% |
| 2026-06 | $126.34 | -6.0% |
| 2026-07 | $130.21 | +3.1% |
| 2026-08 | $146.34 | +12.4% |
| 2026-09 | $149.05 | +1.9% |
| 2026-10 | $170.68 | +14.5% |
| 2026-10 | $170.68 | +0.0% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-09 | $2.05 | $8.28B |
| 2026-10-29 | $2.19 | $7.81B |
| 2026-08-04 | $-7.25 | $7.40B |
| 2026-05-07 | $1.91 | $6.91B |
| 2026-02-10 | $1.81 | $7.69B |
| 2025-10-30 | $2.13 | $7.45B |
| 2025-08-07 | $1.96 | $6.98B |
Price
| Price | $170.68 (closing price, October 30, 2026) |
| Market Cap | $211.6B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 16.26 |
| EV / EBITDA | 281.20 |
| Dividend Yield | 1.90% |
Financial Health
| Debt / Equity | 2.01 |
| Current Ratio | 1.38 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 4.13 |